Mark D. Rahn

MTI Partners Ltd (MTI Partners) is an independent venture capital firm founded in 1983. The firm is headquartered in UK.

Bioxydyn Ltd. provides magnetic resonance imaging applications and services. Its services include imaging protocol and charter, on-site and remote training, quality management, and quantitative imaging biomarkers. The company was founded by Geoffrey James Martin Parker in 2009 and is headquartered in Manchester, the United Kingdom.

Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom.

APIS Assay Technologies Ltd. engages in clinical potential of systems biology in the diagnosis of treatment. The company is headquartered in Manchester, the United Kingdom.

Cable Sense Ltd. provides mapping and monitoring of structured cabling systems. It designs cable scanning products, to be used in a telecommunications room or an office server environment, which will automate management of computer network cabling. Its technology enables the network cable status and connectivity information to be determined without disruption to the cable connection. The company was founded on November 11, 2008 and is headquartered in Lancaster, the United Kingdom.

Arvia Technology Ltd. provides water treatment and conservation technology and solutions. It products the Arvia Organics Destruction Cell (ODC) is a water and wastewater treatment system designed to reduce recalcitrant Chemical Oxygen Demand (COD), remove colour and destroy micro-pollutants. It serves to the chemicals, food, beverage, nuclear, pharmaceuticals and utilities. The company was founded by Nigel Willis Brown and Edward Roberts in 2007 and is headquartered in Warrington, the United Kingdom.